Brendan Chen

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 262 citations

Bacterial Resistance, Antimicrobial Susceptibility, Health Sciences +12

Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection

Bryce K. Perler, Brendan Chen, Emmalee Phelps et al. · Journal of Clinical Gastroenterology · 2020 · 52 citations

Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy

Boudewijn L. M. de Jonge, Grant K. Walkup, Sushmita D. Lahiri et al. · Antimicrobial Agents and Chemotherapy · 2013 · 44 citations · Full text

Bioorganic Chemistry, Antibiotic Adjuvant, Validate Ppat +22

Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Optimization of antibacterial activity

S. Stokes, Hoan K. Huynh, Madhusudhan Gowravaram et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 33 citations · Full text

Biochemistry, Natural Sciences, Antibacterial Activity +9

Transabdominal robotic repair of a congenital right diaphragmatic hernia containing an intrathoracic kidney: a case report

Brendan Chen, Brendan M. Finnerty, Neal J. Schamberg et al. · Journal of Robotic Surgery · 2015 · 27 citations

Urology, Hernia Surgery, Intrathoracic Kidney +5